Alvotech Begins Trading on Nasdaq Stockholm, Expands Nordic Presence

Alvotech Begins Trading on Nasdaq Stockholm, Expands Nordic Presence

Alvotech, the Icelandic biopharmaceutical company specialising in developing and manufacturing biosimilar medicines, began trading today on Nasdaq Sto...

Trading in shares of biotechnology company Alvotech began on the Nasdaq stock market in Stockholm today. In a statement from the company, it is stated that the company's listing on the market there is intended to "increase the company's visibility among market participants in Scandinavia and Europe, increase trading in the company's shares and broaden the shareholder base". In addition to the market in Sweden, the company is listed on the main m…

Trading in Alvotech shares begins today on the Nasdaq market in Stockholm, Sweden. The company's shares will be listed simultaneously on three major markets - Nasdaq in the United States, Nasdaq in Iceland and Nasdaq in Stockholm.